Generate Biomedicines
GENB
#5747
Rank
C$1.76 B
Marketcap
C$13.68
Share price
-8.00%
Change (1 day)
N/A
Change (1 year)

EPS for Generate Biomedicines (GENB)

EPS in 2026 (TTM): C-$3.83

According to Generate Biomedicines's latest financial reports the company's current EPS (TTM) is C-$3.92. In 2025 the company made an earnings per share (EPS) of C-$3.13 a decrease over its 2024 EPS that were of C-$3.00.

EPS history for Generate Biomedicines from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$3.8322.41%
2025C-$3.134.33%
2024C-$3.00